SKI Market

A+| A| A-|

Indian Indices

Sensex

77,562.90 2,946.32
( 3.95%)

Global Indices

Nasdaq

46,614.19 -76.70
(-0.16%)

Dow Jones

6,639.23 6.40
(0.10%)

Hang Seng

56,345.93 2,916.37
(5.46%)

Nikkei 225

10,596.41 247.62
(2.39%)

Forex

USD-INR

92.93 0.25
(0.27%)

EUR-INR

107.23 0.49
(0.46%)

GBP-INR

122.94 0.71
(0.58%)

JPY-INR

0.58 0.00
(0.32%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Concord Biotech Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543960

INE338H01029

174.4719509

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

CONCORDBIO

33.99

10796.92

EPS(TTM)

Face Value()

Div & Yield %

30.36

0.85

Back

orient paper & industries ltd

Shreyans Industries reports standalone net loss of Rs 2.55 crore in the December 2025 quarter

Feb 10,2026

Net loss of Shreyans Industries reported to Rs 2.55 crore in the quarter ended December 2025 as against net profit of Rs 9.10 crore during the previous quarter ended December 2024. Sales declined 6.17% to Rs 159.20 crore in the quarter ended December 2025 as against Rs 169.66 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	159.20	169.66	-6
OPM %	-2.46	9.39	-
PBDT	0.03	16.89	-100
PBT	-3.89	13.02	PL
NP	-2.55	9.10	PL

77,562.90 2,946.32 ( 3.95%)

46,614.19 -76.70 (-0.16%)

6,639.23 6.40 (0.10%)

56,345.93 2,916.37 (5.46%)

10,596.41 247.62 (2.39%)

92.93 0.25 (0.27%)

107.23 0.49 (0.46%)

122.94 0.71 (0.58%)

0.58 0.00 (0.32%)